TCL Archive Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds May 31, 2002
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
